Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART.
<h4>Introduction</h4>Clinical disadvantages of initiating ART at low CD4 counts have been clearly demonstrated but whether any excess risk remains even after reaching relatively high/safe CD4 levels remains unclear. We explore whether individuals starting ART with <500 CD4 cells/μL wh...
Main Authors: | Nikos Pantazis, Vasilios Paparizos, Vasilios Papastamopoulos, Simeon Metallidis, Anastasia Antoniadou, Georgios Adamis, Mina Psichgiou, Maria Chini, Helen Sambatakou, Georgios Chrysos, Nikolaos V Sipsas, Charalambos Gogos, Emmanouil Barbunakis, Periklis Panagopoulos, Olga Katsarou, Giota Touloumi, Athens Multicenter AIDS Cohort Study (AMACS) |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0283648 |
Similar Items
-
Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART
by: Nikos Pantazis, et al.
Published: (2023-01-01) -
Changes in Body Mass Index after Initiation of Antiretroviral Treatment: Differences by Class of Core Drug
by: Nikos Pantazis, et al.
Published: (2022-07-01) -
The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort.
by: Nikos Pantazis, et al.
Published: (2018-01-01) -
Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece.
by: Giota Touloumi, et al.
Published: (2020-01-01) -
HIV cascade of care in Greece: Useful insights from additional stages.
by: Georgia Vourli, et al.
Published: (2018-01-01)